Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.9 USD | -0.24% | -4.27% | -12.04% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.04% | 1.07TCr | |
+48.64% | 5.67TCr | |
-6.44% | 3.94TCr | |
+38.14% | 3.9TCr | |
+14.28% | 2.67TCr | |
-11.17% | 2.69TCr | |
-21.40% | 1.9TCr | |
+25.64% | 1.23TCr | |
+0.96% | 1.23TCr | |
+27.04% | 1.2TCr |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280